Galetzka, Christin,Rundfeldt, Chris,Rupp, Roland,Andersen, Peder M.
申请号：
AU2014314230
公开号：
AU2014314230A1
申请日:
2014.08.26
申请国别(地区):
AU
年份:
2016
代理人:
摘要：
The present invention relates to pharmaceutical compositions containing dimethyl fumarate (DMF), More specifically, the present invention relates to a pharmaceutical composition for oral use in treating hyperproliferative, inflammatory or autoimmune disorders by administering a low daily dosage in the range of 410 mg ± 5% or 400 mg ± 5% dimethyl fumarate, wherein the pharmaceutical formulation is in the form of an erosion matrix tablet.
